NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Praj Industries (PRJ) Research Report

Key Highlights

  • Praj Industries expects FY27 to be a recovery year driven by improved order inflows and better utilization of the GenX facility.
  • The GenX facility is expected to break even at revenue of INR4-5 billion, despite elevated fixed costs.
  • The company is undergoing a structural shift in its 1G ethanol business, transitioning from greenfield to brownfield opportunities and services-led revenue.

Business Segments

Read also: Oshea Herbals Aims for Rs 650 Crore Revenue Amidst Expansion Efforts

  • CBG Segment: A healthy pipeline of INR10 billion exists, although execution remains constrained by feedstock and offtake challenges. Recent policy support for CBG blending into gas pipelines improves long-term visibility.
  • SAF (Sustainable Aviation Fuel): Emerging as a key global opportunity, Praj Industries is focusing on high-value engineering mandates.
  • Iso-butanol: An emerging alternative fuel, with potential for growth.
  • Services Segment: Gaining traction as a stable, annuity-like revenue stream.

Valuation and Recommendation

  • The stock is trading at a P/E of 28.2x/21.0x on FY27/28E.
  • We maintain our 'Accumulate' rating on the stock, valuing it at a P/E of 26x for Sep'27E, with a target price of INR340.

Investor Takeaway

Investors should consider Praj Industries as a potential recovery play in FY27.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.